Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
To compare the early antiviral activity (complete early virologic response rate; cEVR) of GS-9190 versus placebo, in combination with peginterferon alfa 2a (PEG) and ribavirin (RIBA), following 12 weeks of therapy
Inclusion criteria
- Genotype-1 Chronic Hepatitis C Virus (HCV) Infection